Dr. Fernanda Salgado, MD

Dr. Salgado practices at Optum Surgery Center - Long Beach in Long Beach, California.

Dr. Salgado's NPI, 1093256349, was assigned on March 19, 2017. Dr. Salgado graduated from Rutgers New Jersey Medical School in 2017. Dr. Salgado holds California license G172150.

Dr. Salgado's primary practice is Optum Surgery Center - Long Beach, at 2600 Redondo Avenue, Long Beach, CA 90806. The practice phone is (562) 988-7147.

Dr. Salgado's primary practice is Optum Surgery Center - Long Beach in Long Beach, California. The medical group on file is Optum - Downtown Los Angeles. Dmand AI also links Dr. Salgado to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salgado practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Salgado's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Salgado is board certified in dermatology by the American Board of Dermatology. Dr. Salgado is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes and psoriasis among the conditions Dr. Salgado treats.

CMS data shows 339 Medicare services from Dr. Salgado across 6 procedure codes in 2024, for 97 Medicare patients. Medicare paid $13,396 for them. Every service was in an office.

CMS counts 97 Medicare patients who saw Dr. Salgado in 2024. The largest group is 65 to 74, with 53 patients. 74% of them have high cholesterol, and 69% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Salgado's median patient age at 69, with 64% women.

In 2024, Dr. Salgado wrote 654 Medicare Part D claims for 285 patients. 88% of them were for generic drugs. CMS names the drug for 531 of them, across 14 drugs with 11 or more claims each, at $193,610 in total drug cost. In 2023, CMS named 837 claims across 20 drugs.

Dr. Salgado accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 79 procedures of removal of skin lesions by Dr. Salgado, more than 74% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Salgado, published from 2017 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Hepatitis A, Hepatitis A Vaccines and Socioeconomic Factors. Dr. Salgado has published most often in Cutis. Dr. Salgado's most frequent co-authors are Marc Z. Handler, MD, Douglas M. Campbell, MD and Jessica Scheel Connett, MD.

CMS Open Payments shows 104 general payments to Dr. Salgado from 17 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $713.

Dr. Salgado graduated from Rutgers New Jersey Medical School in 2017.

Dr. Salgado is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.